• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Generic Adcirca is Coming!

August 23, 2018 By Dr. Jeremy Feldman

generic medication

After many years under patent protection, the generic medication Tadalafil will soon be available. What does this mean for patients? Hopefully generic Tadalafil will be much less expensive than Adcirca.  We can look back at what happened with a similar medicine, Revatio, when it went generic as sildenafil.

Pricing

We don’t know precise pricing but we expect deep discounts relative to the $25-40,000 price tag. Typically prices continue to drop as more generic manufacturers enter the market.  Once there are more than three generic manufacturers, prices can drop profoundly.  For example, branded Revatio was more than $10 per pill prior to release of generic sildenafil.  Currently sildenafil costs about $0.40 per pill without any insurance.  Be sure to check with your insurance as well as with GoodRx.com.

Will I be able to choose between branded Adcirca and generic Tadalafil?

Generally most insurance companies will automatically switch patients to a generic medication unless their physician specifically orders the branded medication.  Specialty pharmacies are already checking with the prescribing doctor about switching to the generic medication.  If your doctor insists on the branded Adcirca, you can expect to have a much higher co-pay.

Is generic Tadalafil any less effective than Adcirca?

No.  The medication must be the same.  In order to get FDA approval it mush be shown to be very similar. For an oral medication like Tadalafil I don’t expect any meaningful differences.

Are side effects and risks any different with a generic medication?

No.  The active ingredient is the same as the branded medication.

When will generic Tadalafil be available?

We expect by the beginning of September that Tadalafil will be in pharmacies.

How will generic Tadalafil impact grants from charitable foundations?

We don’t expect this to make much difference. The money you receive from the charitable foundation may be applied to your other PAH medications.  Stay tuned for more details on this.

Filed Under: Pulmonary Hypertension Treatments

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Dr. Jeremy Feldman

FAQ’s: CTEPH, Blood Clots, Corrective Surgery, PAH Centers

By Dr. Jeremy Feldman

Your Questions Answered Who should be worried about CTEPH? Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Reviewing PVOD Diagnosis

I Was Misdiagnosed With PAH

By Dr. Jeremy Feldman

We look forward to and read every email readers send us through our contact form.  We find the questions and comments

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives